The current analyst and expert consensus on Vascular Biogenics is Strong Buy with 0 strong sell and 3 strong buy opinions. The current projected target price consensus is 14.0 with 3 analysts opinions. The most common way Vascular Biogenics analysists use to provide recommendation to public is financial statements analysis. Many experts also interview Vascular Biogenics executives and customers to further validate their buy or sell advice. Please note, the number of analysists providing the opinion is not sufficient to provide adequate consensus on Vascular Biogenics. We encourage you to use your own analysis of Vascular Biogenics to validate this buy or sell advice. Vascular Biogenics buy or sell recommendation module provides average expert sentiment on the projected Vascular Biogenics target price to derive its highest and lowest estimates based on projected price volatility of 5.196. Also please take a look at Macroaxis Advice on Vascular Biogenics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the prospective of investor risk tolerance and investment horizon.